Farokhnia M, Rentsch CT, Chuong V, McGinn MA, Elvig SK, Douglass EA, et al
Liraglutide, marketed as Saxenda, was our first GLP-1 approved for weight loss
Flexible Spending Accounts (FSA) or Health Savings Accounts (HSA) Many patients use FSA or HSA funds to pay for semaglutide prescriptions, consultations, and related medical supplies
Clinical trial data revealed that 1.5% of patients on the 0.5mg dose developed gallstones compared to 0% in the placebo group, with 90% of these cases being serious enough to require cholecystectomy (surgical gallbladder removal) yet this information wasnt prominently disclosed to prescribers or patients for over four years
Accessing a tirzepatide vial requires adherence to aseptic technique to prevent contamination and ensure medication safety
A reused needle is duller, more painful, and a contamination risk